Vasodilatory mechanism of unoprostone isopropyl on isolated rabbit ciliary artery

References

• Flammer J. The vascular concept of glaucoma. Surv Ophthalmol.1994;38:Suppl:s3—s6.
   Google Scholar
• Yamamoto T, Kitazawa Y. Vascular pathogenesis of normal-tension glaucoma: A possible pathogenetic factor, other than intraocular pressure, of glaucomatous optic neuropa-thy. Prog Retin Eye Res.1998;17:127–143.
   PubMed Web of Science ®Google Scholar
• Anderson DR. Introductory comments on blood flow autoregulation in the optic nerve head and vascular risk factors in glaucoma. Surv Ophthalmol.1999;43:Suppl 1:s5–s9.
   Google Scholar
• Tamaki Y, Araie M, Tomita K, Nagahara M, Tomidokoro A. Effect of topical B-blockers on tissue blood flow in the human optic nerve head. Curr Eye Res.1997;16:1102–1110.
   Google Scholar
• Hayashi-Morimoto R, Yoshitomi T, Ishikawa H, Hayashi E, Sato Y, Effects of f3 antagonists on mechanical properties in rabbit ciliary artery. Graefes Arch Clin Exp Ophthalmol.1999;237:661–667.
   PubMed Web of Science ®Google Scholar
• Yoshitomi T, Yamaji K, Ishikawa H, Ohnishi Y. Vasodila-tory effects of nipradilol, an alpha and B adrenergic blocker with nitric oxide releasing action, in rabbit ciliary artery. Exp Eye Res.2002;75:669–676.
   PubMed Web of Science ®Google Scholar
• Azuma I, Masuda K, Kitazawa Y, Takase M, Yamamura H. Double-masked comparative study of UF-021 and timolol ophthalmic solutions in patients with primary open-angle glaucoma or ocular hypertension. Jpn J Ophthalmol.1993;37: 514–525.
   Google Scholar
• Tons CB, Camras CB, Yablonski ME, Brubaker RIP. Effects of exogenous prostaglandins on aqueous humor dynamics and blood-aqueous barrier function. Surv Ophthalmol.1997;41:Suppl 2, s69–s75.
   Google Scholar
• De Arruda Mello PA, Yannoulis NC, Hague RM. Safety of unoprostone isopropyl as mono- or adjunctive therapy in patients with primary open-angle glaucoma or ocular hypertension. Drug Saf2002;25:583–597.
   PubMed Web of Science ®Google Scholar
• Taniguchi T, Hague MS, Sugiyama K, Hori N, Kitazawa Y. Ocular hypotensive mechanism of topical isopropyl uno-prostone, a novel prostaglandin metabolite-related drug, in rabbits. J Ocul Pharmacol Ther.1996;12:489–498.
   Google Scholar
• Serle JB, Podos SM, Kitazawa Y, Wang RE A comparative study of latanoprost (Xalatan) and isopropyl unoprostone (Rescula) in normal and glaucomatous monkey eyes. Jpn J Ophthalmol.1998;42:95–100.
   PubMed Web of Science ®Google Scholar
• Ueno R, Yoshida S, Deguchi T, Kato I, Oda T, Hayashi Y, Kuno S. The intraocular pressure lowering effects of UF-021, a novel prostaglandin related compound, in animals. Nippon Ganka Gakkai Zasshi.1992;96: 462–468.
   Google Scholar
• Sakurai M, Araie M, Oshika T, Mori M, Masuda K, Ueno R, Takase M. Effects of topical application of UF-021, a novel prostaglandin derivative, on aqueous humor dynam-ics in normal human eyes. Jpn J Ophthalmol.1991; 35:156–165.
   Google Scholar
• Sakurai M, Araie M, Oshika T, Mori M, Shoji N, Masuda K. Effects of topical application of UF-021, a novel prostaglandin-related compound, on aqueous humor dynamics in rabbit. Jpn J Ophthalmol.1993;37:252–258.
   PubMed Web of Science ®Google Scholar
• Kashiwagi K, Iizuka Y, Tsukahara S. Metabolites of iso-propyl unoprostone as potential ophthalmic solutions to reduce intraocular pressure in pigmented rabbits. Jpn J Pharmacol.1999;81:56–62.
   Google Scholar
• Polska E, Doelemeyer A, Luksch A, Ehrlich P, Kaehler N, Percicot CL, Lambrou GN, Schmetterer L. Partial antago-nism of endothelin 1-induced vasoconstriction in the human choroid by topical unoprostone isopropyl. Arch Ophthalmol.2002;120:348–352.
   PubMedGoogle Scholar
• Makimoto Y, Sugiyama T, Kojima S, Azuma I. Long-term effect of topically applied isopropyl unoprostone on micro-circulation in the human ocular fundus. Jpn J Ophthalmol.2002;46:31–35.
   PubMed Web of Science ®Google Scholar
• Tamaki Y, Araie M, Tomita K, Nagahara M, Sandoh S, Tomidokoro A. Effect of topical unoprostone on circulation of human optic nerve head and retina. J Ocul Pharmacol Ther.2001;17:517–527.
   PubMed Web of Science ®Google Scholar
• Sugiyama T, Azuma I. Effect of UF-021 on optic nerve headcirculation in rabbits. Jpn J Ophthalmol.1995;39:124–129.
   PubMed Web of Science ®Google Scholar
• Yu DY, Su EN, Cringle SJ, Schoch C, Percicot CP, Lambrou GN. Comparison of the vasoactive effects of the docosanoid unoprostone and selected prostanoids on isolated perfused retinal arterioles. Invest Ophthalmol Vis Sci.2001;42:1499–1504.
   PubMed Web of Science ®Google Scholar
• Hayashi E, Yoshitomi T, Ishikawa H, Hayashi R, Shimizu K. Effects of isopropyl unoprostone on rabbit ciliary artery. Jpn J Ophthalmol.2000;44:214–220.
   Google Scholar
• Mulvany MJ, Halpern W. Mechanical properties of vascu-lar smooth muscle cells in situ. Nature.1976;260:617–619.
   PubMed Web of Science ®Google Scholar
• Mulvany MJ, Halpern W. Contractile properties of small arterial resistance vessels in spontaneously hypertensive and normotensive rats. Circ Res.1977;41:19–26.
   PubMed Web of Science ®Google Scholar
• Schilling L, Kanzler C, Schmiedek P, Ehrenreich H. Char-acterization of the relaxant action of urocortin, a new peptide related to corticotropin-releasing factor in the rat isolated basilar artery. Br J Pharmacol.1998;125:1164–1171.
   PubMed Web of Science ®Google Scholar
• Brunner F, Schmidt K, Nielsen EB, Mayer B. Novel guany-ly1 cyclase inhibitor potently inhibits cyclic GMT) accumu-lation in endothelial cells and relaxation of bovine pulmonary artery. J Pharmacol Exp Ther.1996;277:48–53.
   PubMed Web of Science ®Google Scholar
• Putney JW. A model for receptor-regulated calcium entry. Cell Calcium.1986;7:1–12.
   PubMed Web of Science ®Google Scholar
• Yoshitomi T, Ishikawa H, Hayashi E. Pharmacological effects of pilocarpine on rabbit ciliary artery. Curr Eye Res.2000;20:254–259.
   PubMed Web of Science ®Google Scholar
• Tomidokoro A, Araie M, Tamaki Y, Tomita K. In vivomea-surement of iridial circulation using laser speckle phenom-enon. Invest Ophthalmol Vis Sci.1998;39:364–371.
   PubMed Web of Science ®Google Scholar
• Brunner F, Stessel H, Kukovetz WR. Novel guanylyl cyclase inhibitor, ODQ reveals role of nitric oxide, but not of cyclic GMP in endothelin-1 secretion. FEBS Lett.1995;376: 262–266.
   Google Scholar
• Thieme H, Stumpff F, Ottlecz A, Percicot CL, Lambrou GN, Wiederholt M. Mechanisms of action of unoprostone on trabecular meshwork contractility. Invest Ophthalmol Vis Sci.2001;42:3193–3201.
   PubMed Web of Science ®Google Scholar
• Kaczorowski GJ, Knaus HG, Leonard RI, Mcmanus 0, Garcia ML. High-conductance calcium-activated potas- sium channels; structure, pharmacology, and function. J Bioenerg Biomembr.1996;28:255–267.
   Google Scholar
• Watanabe C, Matsumoto S, Kin K, Tsuchisaka H, Ueno R. Ocular penetration of UF-021, a new prostaglandin related compound, in the rabbit eye. Nippon Ganka Gakkai Zasshi.1992;96: 335–339.
   Google Scholar
• Mcfadzean I, Gibson A. The developing relationship between receptor-operated and store-operated calcium channels in smooth muscle. Br J Pharmacol.2002;135: 1–13.
   PubMed Web of Science ®Google Scholar
• Gustafsson H. Vasomotion and underlying mechanisms in small arteries. An in vitrostudy of rat blood vessels. Acta Physiol Scand SuppL1993;614:1–44.
   PubMedGoogle Scholar
• Laporte R, Laher I. Sarcoplasmic reticulum-sarcolemma interactions and vascular smooth muscle tone. J Vasc Res.1997;34:325–343.
   PubMed Web of Science ®Google Scholar
• Hughes AD. Calcium channels in vascular smooth muscle cells. J Vasc Res.1995;32:353–370.
   PubMed Web of Science ®Google Scholar
• Orallo F. Regulation of cytosolic calcium levels in vascular smooth muscle. Pharmacol Ther.1996;69:153–171.
   PubMed Web of Science ®Google Scholar
• Gibson A, Mcfadzean I, Wallace P, Wayman CP. Capacita-tive Ca' entry and the regulation of smooth muscle tone. Trends Pharmacol Sci.1998;19:266–269.
   PubMed Web of Science ®Google Scholar
• Wallace P, Ayman S, Mcfadzean I, Gibson A. Thapsigargin-induced tone and capacitative calcium influx in mouse anococcygeus smooth muscle cells. Naunyn Schmiedebergs Arch Pharmacol.1999;360:368–375.
   PubMed Web of Science ®Google Scholar